Natural Killer Cells: Characteristics and Regulation of Activity
1979; Wiley; Volume: 44; Issue: 1 Linguagem: Inglês
10.1111/j.1600-065x.1979.tb00267.x
ISSN1600-065X
AutoresRonald B. Herberman, Julie Y. Djeu, H. David Kay, John R. Ortaldo, Carlo Riccardi, Guy D. Bonnard, Howard T. Holden, Roberto Fagnani, Angela Santoni, Paolo Puccetti,
Tópico(s)Immunotherapy and Immune Responses
ResumoImmunological ReviewsVolume 44, Issue 1 p. 43-70 Natural Killer Cells: Characteristics and Regulation of Activity Ronald B. Herberman, Ronald B. Herberman Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorJulie Y. Djeu, Julie Y. Djeu Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorH. David Kay, H. David Kay Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorJohn R. Ortaldo, John R. Ortaldo Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorCarlo Riccardi, Carlo Riccardi Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorGuy D. Bonnard, Guy D. Bonnard Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorHoward T. Holden, Howard T. Holden Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorRoberto Fagnani, Roberto Fagnani Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorAngela Santoni, Angela Santoni Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorPaolo Puccetti, Paolo Puccetti Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this author Ronald B. Herberman, Ronald B. Herberman Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorJulie Y. Djeu, Julie Y. Djeu Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorH. David Kay, H. David Kay Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorJohn R. Ortaldo, John R. Ortaldo Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorCarlo Riccardi, Carlo Riccardi Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorGuy D. Bonnard, Guy D. Bonnard Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorHoward T. Holden, Howard T. Holden Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorRoberto Fagnani, Roberto Fagnani Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorAngela Santoni, Angela Santoni Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this authorPaolo Puccetti, Paolo Puccetti Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland 20014; Litton Bionetics, Inc., Kensington, Maryland 20795, USA; and Institute of Pharmacology, University of Perugia, Perugia, Italy.Search for more papers by this author First published: April 1979 https://doi.org/10.1111/j.1600-065X.1979.tb00267.xCitations: 453AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Arnaud-Battandier, F., Bundy, B.M, & Nelson, D.L. (1978) Natural killer cells in guinea pig spleen bear Fc receptors. Eur. J. Immunol. 8, 400. 10.1002/eji.1830080606 CASPubMedWeb of Science®Google Scholar Bakacs, T., Gergely, P., Cornain, S. & Klein, E. (1977) Characterization of human lymphocyte subpopulations for nonselective cytotoxicity against tumor-derived monolayer cultures. Int. J. Cancer 19, 441. 10.1002/ijc.2910190402 CASPubMedWeb of Science®Google Scholar Becker, S. & Klein, E. (1977) Decreased "natural killer" NK effect in tumor bearing mice and its relation to the immunity against oncorna virus determined cell surface antigens. Eur. J. Immunol. 6, 892. 10.1002/eji.1830061211 Web of Science®Google Scholar Bolhuis, R.L.H. (1977) Cell-mediated immunity to carcinoma of the urinary bladder. Specificity of the reaction and the nature of the effector cells, pp. 1–169. Radiobiological Institute of the Organization for Health Research TNO, Rijsivijk, The Netherlands . Google Scholar Bolhuis, R.L.H., Schuit, H.R.E., Nooyen, A.M. & Ronteltap, (1978) Characterization of natural killer (NK)-cells and killer (K)-cells in human blood: Discrimination between NK- and K-cell activities. Eur. J. Immunol. In press. 10.1002/eji.1830081012 PubMedWeb of Science®Google Scholar Bonmassar, E., Riccardi, C., Campanile, F., Iorio, A., Puccetti, P. & Herberman, R. (1978) Radioresistant inhibition of tumors (RIT): biological and pharmacological studies. In: Current Trends in Tumor Immunology., eds. R.A. Reisfeld, S. Ferrone & R.B. Herberman, Garland STPM Press, New York . In press. Google Scholar Bonnard, G.D., Kay, H.D., Herberman, R.B., Ortaldo, J.R., Djeu, J., Pfiffner, K.J. & Oehler, J.R. (1978) Models for the mechanism of natural cell-mediated cytotoxicity. I. Relationship to antibody-dependent cell-mediated cytotoxicity. In: Prospective in Immunology, eds. G. Riethmuller, P. Wernet & G. Cudkowicz, Academic Press, New York . In press. Google Scholar Campanile, E., Crino, L., Bonmassar, E., Houchens, D. & Goldin, A. (1977) Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice. Cancer Res. 37, 394. PubMedWeb of Science®Google Scholar Chess, L., MacDermott, R.P. & Schlossman, S.F. (1974) Immunologic functions of isolated human lymphocyte subpopulations. I. Qualitative isolation of human T and B cells and response to mitogens. J. Immunol. 113, 1113. CASPubMedWeb of Science®Google Scholar Cudkowicz, G. & Yung, Y.P. (1977) Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the antimacrophage agent Seakem carrageenan. J. Immunol. 119, 483. CASPubMedWeb of Science®Google Scholar Dean, J.H., Silva, J.S., McCoy, J.L., Leonard, C.M., Cannon, G.B. & Herberman, R.B. (1975) Functional activities of rosette-separated human peripheral blood leukocytes. J. Immunol. 115, 1449. CASPubMedWeb of Science®Google Scholar de Landazuri, M.O., Kedar, E. & Fahey, J.L. (1974) Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma. J. Natl. Cancer Inst. 52, 147. PubMedWeb of Science®Google Scholar de Landazuri, M.O., Bonnard, G.D. & Herberman, R.B. (1978) In preparation. Google Scholar DeVries, J.E., Cornain, S. & Rumke, P. (1974) Cytotoxicity of non-T verus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells. Int. J. Cancer 14, 427. 10.1002/ijc.2910140402 CASPubMedGoogle Scholar Djeu, J.Y., Heinbaugh, J.A., Holden, H.T. & Herberman, R.B. (1978a) Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. In press. Google Scholar Djeu, J.Y., Heinbaugh, J., Vieira, W., Holden, H.T. & Herberman, R.B. (1978b) The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I:C. Submitted for publication. Google Scholar Eremin, O., Ashby, J. & Stephens, J.P. (1978a) Human natural cytotoxicity in the blood and lymphoid organs of health donors and patients with malignant disease. Int. J. Cancer 21, 35. 10.1002/ijc.2910210108 CASPubMedWeb of Science®Google Scholar Eremin, O., Coombs, R.R.A., Plumb, D. & Ashby, J. (1978b) Characterization of the human natural killer (NK) cell in blood and lymphoid organs. Int. J. Cancer 21, 42. 10.1002/ijc.2910210109 CASPubMedWeb of Science®Google Scholar Gidlund, M., Örn, A., Wigzell, H., Senik, A. & Gresser, I. (1978) Enhanced NK cell activity in mice infected with interferon and interferon inducers. Nature 223, 259. Google Scholar Haller, O., Kiessling, R., & Ouml;rn, A., Kärre, K., Nilsson, K. & Wigzell, H. (1977) Natural cytotoxicity to human leukemia mediated by mouse non-T cells. Int. J. Cancer 20, 93. 10.1002/ijc.2910200116 CASPubMedWeb of Science®Google Scholar Harmon, R.C., Clark, E.A., O'Toole, C. & Wicker, L.S. (1977) Resistance of H-2 heterozygous mice to prenatal tumors. Hybrid resistance and natural cytotoxicity to EL-4 are controlled by the H-2D-Hh-1 region. Immunogenetics 4, 601. 10.1007/BF01575694 Web of Science®Google Scholar Herberman, R.B. & Holden, H.T. (1978) Natural cell-mediated immunity. In: Advances Cancer Res., eds. G. Klein & S. Weinhouse, Vol. 27, p. 305. Academic Press, New York . Google Scholar Herberman, R.B., Nunn, M.E., Lavrin, D.H. & Asofsky, R. (1973) Effect of antibody to φ antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus. J. Natl. Cancer Inst. 51, 1509. 10.1093/jnci/51.5.1509 CASPubMedWeb of Science®Google Scholar Herberman, R.B., Ting, C.C., Kirchner, H., Holden, H., Glaser, M., Bonnard, G.D. & Lavrin, D. (1974) Effector mechanisms in tumor immunity. In: Progress in Immunology. II, eds. L. Brent & J. Holborow, p. 285. North-Holland Publishing Co., Amsterdam . Google Scholar Herberman, R.B., Nunn, M.E., Holden, H.T. & Lavrin, D.H. (1975a) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. IL Characterization of effector cells. Int. J. Cancer 16, 230. 10.1002/ijc.2910160205 CASPubMedWeb of Science®Google Scholar Herberman, R.B., Nunn, M.E. & Lavrin, D.H. (1975b) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16, 216. 10.1002/ijc.2910160204 CASPubMedWeb of Science®Google Scholar Herberman, R.B., Nunn, M.E., Holden, H.T., Staal, S. & Djeu, J.Y. (1977) Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int. J. Cancer 19, 555. 10.1002/ijc.2910190417 PubMedWeb of Science®Google Scholar Herberman, R.B., Djeu, J.Y., Ortaldo, J.R., Holden, H.T., West, W.H. & Bonnard, G.D. (1978a) Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. Cancer Treatment Reports. In press. Google Scholar Herberman, R.B., Holden, H.T., West, W.H., Bonnard, G.D. Santoni, A., Nunn, M.E., Kay, H.D. & Ortaldo, J.R. (1978b) Cytotoxicity against tumors by NK and K cells. In: Proceedings of International Symposium on Tumor Associated Antigens and Their Specific Immune Response, In press. Google Scholar Herberman, R.B., Nunn, M.E. & Holden, H.T. (1978c) Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. J. Immunol. 121, 304. CASPubMedWeb of Science®Google Scholar Holden, H.T., McIntire, K.R. & Herberman, R.B. (1978) In preparation. Google Scholar Iorio, A., Campanile, F., Neri, M., Spreafico, F., Goldin, A. & Bonmassar, E. (1978) Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice. J. Immunol. 120, 1679. PubMedWeb of Science®Google Scholar Kaplan, J. & Callewaert, D.M. (1978) Expression of human T-lymphocyte antigens by natural killer cells. J. Natl. Cancer Inst. 60, 961. CASPubMedWeb of Science®Google Scholar Kay, H.D., Bonnard, G.D., West, W.H. & Herberman, R.B. (1977) A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J. Immunol. 118, 2058. CASPubMedWeb of Science®Google Scholar Kay, H.D., Bonnard, G.D. & Heberman, R.B. (1978a) Evaluation of the role of IgG antibodies in human natural cell-mediated cytotoxicity against the myeloid cell line K-562. J. Immunol. In press. Google Scholar Kay, H.D., Fagnani, R. & Bonnard, G.D. (1978b) Cytotoxicity against a myeloid leukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG. Submitted for publication. Google Scholar Keller, R. (1978) Macrophage-mediated natural cytotoxicity against various target cells in vitro. I. Comparison of tissue macrophages from diverse anatomic sites and from different strains of rats and mice. Br. J. Cancer 37, 732. 10.1038/bjc.1978.111 CASPubMedWeb of Science®Google Scholar Kiessling, R., Klein, E., Pross, H. & Wigzell, H. (1975a) "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Europ. J. Immunol. 5, 117. 10.1002/eji.1830050209 PubMedWeb of Science®Google Scholar Kiessling, R., Petrányi, G., Klein, G. & Wigzell, H. (1975b) Genetic variation of in vitro cytolytic activity and in vivo rejection potential of nonimmunized semisyngeneic mice against a mouse lymphoma line. Int. J. Cancer 15, 933. 10.1002/ijc.2910150608 CASPubMedWeb of Science®Google Scholar Kiessling, R., Petrányi, G., Kärre, K., Jondal, M., Tracey, D. & Wigzell, H. (1976) Killer cells: a functional comparison between natural, immune T cell and antibody dependent in vitro systems. J. Exp. Med. 143, 772. 10.1084/jem.143.4.772 CASPubMedWeb of Science®Google Scholar Kiessling, R., Hochman, P.S., Haller, O., Shearer, G.M., Wigzell, H. & Cudkowicz, G. (1977) Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur, J. Immunol. 7, 655. 10.1002/eji.1830070915 PubMedWeb of Science®Google Scholar Kirchner, H., Hirt, H.M., Becker, H. & Munk, K. (1977) Production of an antiviral factor by murine spleen cells after treatment with Corynebacterium parvum. Cell. Immunol. 31, 172. 10.1016/0008-8749(77)90016-8 CASPubMedWeb of Science®Google Scholar Kiuchi, M. & Takasugi, M. (1976) The nonselective cytotoxic cell (N cell). J. Natl. Cancer Inst. 56, 575. 10.1093/jnci/56.3.575 CASPubMedWeb of Science®Google Scholar Koide, Y. & Takasugi, M. (1977) Determination of specificity in natural cell-mediated cytotoxicity by natural antibodies. J. Natl. Cancer In st. 59, 1099. CASPubMedWeb of Science®Google Scholar Koren, H.S., Amos, D.B. & Buckley, R.H. (1978) Natural killing in immunodeficient patients. J. Immunol. 120, 796. CASPubMedWeb of Science®Google Scholar Lee, J.C. & Ihle, J.N. (1977) Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71. J. Immunol. 118, 928. CASPubMedWeb of Science®Google Scholar Levin, A., Massey, R., Deinhardt, F., Schauf, V. & Wolter, J. (1975) Use of 51Cr release microcytotoxicity assay for the study of lymphocytotoxicity and inhibition of lymphocytotoxicity in human breast cancer. In: Neoplasm Immunity: Theory and Application, p. 107, ed. R.G. Crispen, ITR, Chicago . Web of Science®Google Scholar Loor, F. & Roelants, G.E. (1974) High frequency of T lineage lymphocytes in nude mouse spleen. Nature 251, 229. 10.1038/251229a0 CASPubMedWeb of Science®Google Scholar MacFarlan, R.I., Burns, W.H. & White, D.O. (1977) Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells. J. Immunol. 119, 1569. CASPubMedWeb of Science®Google Scholar Mantovani, A., Jerrells, T.R., Dean, J.H. & Herberman, R.B. (1979) Cytolytic and cytostatic activity on tumor cells of circulating human monocytes. Int. J. Cancer, in press. 10.1002/ijc.2910230105 PubMedWeb of Science®Google Scholar McCoy, J., Herberman, R., Perlin, E., Levine, P. & Alford, C. (1973a) 51Cr release cellular lymphocyte cytotoxicity as a possible measure of immunological competence of cancer patients. Proc. Amer. Assoc. Cancer Res. 14, 107. Web of Science®Google Scholar McCoy, J.L., Herberman, R.B., Rosenberg, E.B., Donnelly, F.C., Levine, P.H. & Alford, C. (1973b) 51Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells. Natl. Cancer Inst. Monogr. 37, 59. CASPubMedGoogle Scholar Miller, H.C., Schmiege, S.K. & Rule, A. (1973) Production of fuctional T cells after treatment of bone marrow with thymic factor. J. Immunol. 111, 1005. CASPubMedWeb of Science®Google Scholar Nunn, M.E., Djeu, J.Y., Glaser, M., Lavrin, D.H. & Herberman, R.B. (1976) Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma. J. Natl. Cancer Inst. 56, 393. 10.1093/jnci/56.2.393 CASPubMedWeb of Science®Google Scholar Nunn, M.E. & Herberman, R.B. (1979) Natural cytotoxicity of mouse, rat, and humans against heterologous tumor cells. J. Natl. Cancer Inst. In press. PubMedWeb of Science®Google Scholar Nunn, M.E., Herberman, R.B. & Holden, H.T. (1977) Natural cell-mediated cytotoxicity in mice against nonlymphoid tumor cells and some normal cells. Int. J. Cancer 20, 381. 10.1002/ijc.2910200309 CASPubMedWeb of Science®Google Scholar Oehler, J.R. & Herberman, R.B. (1978) Natural cell-mediated cytotoxicity in rats. IIL Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid. Int. J. Cancer 21, 221. 10.1002/ijc.2910210214 CASPubMedWeb of Science®Google Scholar Oehler, J.R., Campbell, D.A., Jr. & Herberman, R.B. (1971) In vitro inhibition of lymphoproliferative responses to tumor-associated antigens and of lymphoma cell proliferation by rat splenic macrophages. Cell. Immunol. 28, 355. 10.1016/0008-8749(77)90118-6 Web of Science®Google Scholar Oehler, J.R., Lindsay, L.R., Nunn, M.F. & Herberman, R.B. (1978a) Natural cell-mediated cytotoxicity in rats. I. Tissue and strain distribution, and demonstration of a membrane receptor for the Fc portion of IgG. Int. J. Cancer 21, 204. 10.1002/ijc.2910210212 CASPubMedWeb of Science®Google Scholar Oehler, J.R., Lindsay, L.R., Nunn, M.E., Holden, H.T. & Herberman, R.B. (1978b) Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity. Int. J. Cancer 21, 210. 10.1002/ijc.2910210213 CASPubMedWeb of Science®Google Scholar Ojo, E. & Wigzell, H. (1978) Natural killer cells may be the only cells in normal mouse lymphoid populations endowed with cytolytic ability for antibody-coated tumor target ceils. Submitted for publication. Google Scholar Oldham, R.K., Siwarski, D., McCoy, J.L., Plata, E.J. & Herberman, R.B. (1973) Evaluation of a cell-mediated cytotoxicity assay utilizing 125Iododeoxyuridine-labelled tissue-culture target cells. Nat. Cancer Inst. Monogr. 37, 49. PubMedGoogle Scholar Ono, A., Amos, D.B. & Koren, H.S. (1977) Selective cellular natural killing against human leukemic T cells and thymus. Nature 266, 546. 10.1038/266546a0 PubMedWeb of Science®Google Scholar Ortaldo, J.R., Bonnard, G.D. & Herberman, R.B. (1977a) Cytotoxic reactivity of human lymphocytes cultured in vitro. J. Immunol. 119, 1351. CASPubMedWeb of Science®Google Scholar Ortaldo, J.R., Kay, H.D. & Bonnard, G.D. (1977b) In vitro induction of natural killer (NK) and killer (K) cells. In: Regulatory Mechanisms in Lymphocyte Activation: Proceedings 11th Leuk. Culture Conf. ed. D.O. Lucas, p. 542. Academic Press, New York . 10.1016/B978-0-12-458050-3.50086-2 Google Scholar Ortaldo, J.R., Oldham, R.K., Cannon, G.C. & Herberman, R.B. (1977c) Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J. Natl. Cancer Inst. 59, 77. CASPubMedWeb of Science®Google Scholar Ortaldo, J.R., Bonnard, G.D., Kind, P.H. & Herberman, R.B. (1978a) The specificity of spontaneous cytotoxicity of human lymphocytes before and after culture. Proc. Am. Assoc. Cancer Res. 19, 106. Web of Science®Google Scholar Ortaldo, J.R., Bonnard, G.D., McDermott, R.P., Kind, P.H. & Herberman, R.B. (1978b) Cytotoxicity from cultured cells: analysis of precursors involved in generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicity. Submitted for publication. Google Scholar Pape, G.R., Troye, M. & Perlmann, P. (1977) Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture. J. Immunol. 118, 1925. CASPubMedWeb of Science®Google Scholar Peter, H.H., Pavie-Fischer, J., Fridman, W.H., Aubert, C., Cesarini, J., Roubin, R. & Kourilsky, E.M. (1975) Cell-mediated cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (IGR3). J. Immunol. 115, 539. CASPubMedWeb of Science®Google Scholar Pross, H.E. & Jondal, M. (1975) Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin. Exp. Immunol. 21, 226. CASPubMedWeb of Science®Google Scholar Pross, H.F. & Baines, M.G. (1976) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. I. The effect of malignant disease. Int. J. Cancer 18, 593. 10.1002/ijc.2910180508 PubMedWeb of Science®Google Scholar Pross, H.G., Baines, M.G. & Jondal, M. (1977) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells Int. J. Cancer 20, 353. 10.1002/ijc.2910200306 CASPubMedWeb of Science®Google Scholar Pross, H.F., Gupta, S., Good, R.A. & Baines, M.G. (1978) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease. Submitted for publication. Google Scholar Raff, M.C. (1971) Surface antigenic markers for distinguishing T and B lymphocytes in mice. Transpl. Rev. 6, 52. 10.1111/j.1600-065X.1971.tb00459.x PubMedGoogle Scholar Raff, M.C. & Wortis, H.H. (1970) Thymus dependence of θ-bearing cells in the peripheral lymphoid tissues of mice. Immunol. 18, 931. PubMedWeb of Science®Google Scholar Riccardi, C., Fioretti, M.C., Giampietri, A., Puccetti, P., Goldin, A. & Bonmassar, E. (1978a) Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice. J. Natl. Cancer Inst. 60, 1083. CASPubMedWeb of Science®Google Scholar Riccardi, C., Puccetti, P., Santoni, A. & Herberman, R.B. (1978b) Rapid in vivo assay of mouse NK cell activity. Submitted for publication. Google Scholar Roder, J.C. & Kiessling, R. (1978) Target-effector interaction in the natural killer cell system. I. Co-variance and genetic control of cytolyxic and target-cell-binding subpopulations in the mouse. Scand. J. Immunol. 8, 135. 10.1111/j.1365-3083.1978.tb00505.x CASPubMedWeb of Science®Google Scholar Roder, J.C., Rosen, A., Fenyo, E.M. & Troy, F. (1978) Target-effector interactions in the natural killer cell system: the isolation of a target structure on YAC lymphoma cells. Proc. Natl. Acad. Sci. USA. Submitted. Google Scholar Rosenberg, E.B., Herberman, R.B., Levine, P.H., Halterman, R.H., McCoy, J.L. & Wunderlich, J.R, (1972) Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int. J. Cancer 9, 648. 10.1002/ijc.2910090323 CASPubMedGoogle Scholar Rosenberg, E.B., McCoy, J.L., Green, S.S., Donnelly, F.C., Siwarski, D.F., Levine, P.H. & Herberman, R.B. (1974) Destruction of human lymphoid tissue culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J. Natl. Cancer Inst. 52, 345. 10.1093/jnci/52.2.345 CASPubMedWeb of Science®Google Scholar Saksela, E., Häyry, P. & Anderson, L.C. (1978) Identification of the effector cells in human blood displaying spontaneous cytotoxicity to chicken erythrocytes. Eur. J. Immunol. In press. PubMedGoogle Scholar Santoli, D., Trinchieri, G., Zmijewski, C.M. & Koprowski, H. (1976) HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J. Immunol. 117, 765. PubMedWeb of Science®Google Scholar Santoni, A., Herberman, R.B. & Holden, H.T. (1979a) Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. I. Distribution of the reactivity. J. Natl. Cancer Inst. In press. Google Scholar Santoni, A., Herberman, R.B. & Holden, H.T. (1979b) Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells. Submitted for publication. Google Scholar Sendo, F., Aoki, T., Boyse, E.A. & Buafo, C.K. (1975) Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL♂1 cells. J. Natl. Cancer Inst. 55, 603. 10.1093/jnci/55.3.603 CASPubMedWeb of Science®Google Scholar Shellam, G.R. (1977) Studies on a Gross-virus-induced lymphoma in the rat. V. Natural cytotoxic cells are non-T cells. Int. J. Cancer 19, 225. 10.1002/ijc.2910190212 CASPubMedWeb of Science®Google Scholar Stutman, O. (1975) Immunodepression and malignancy. In; Advances in Cancer Research, eds. G. Klein, S. Weinhouse & A. Haddow, Vol. 22, p. 261. Academic Press. New York . Google Scholar Svet-Moldavsky, G.J., Nemirovskaya, B.M., Osipova, T.V., Slavina, E.G., Zinzar, S.N., Karmanova, N.V. & Morozova, L.F. (1974) Interferonogenicity of antigens and "early" cytotoxicity of lymphocytes. Folia Biol. (Prague) 20, 225. CASPubMedWeb of Science®Google Scholar Tagliabue, A., Mantovani, A., Kilgallen, M., Herberman, R.B. & McCoy, J.L. (1978) Natural cytotoxicity mediated by normal mouse monocytes and macrophages and its responsiveness to lymphokines. Submitted for publication. Google Scholar Takasugi, M., Akira, D. & Kinoshita, K. (1975) Granulocytes as effectors in cell-mediated cytotoxicity of adherent target cells. Cancer Res. 35, 2169. PubMedWeb of Science®Google Scholar Takasugi, M., Koide, Y., Akira, D. & Ramseyer, A. (1977a) Specificities in natural cell-mediated cytotoxicity by the cross-competition assay. Int. J. Cancer 19, 291. 10.1002/ijc.2910190303 PubMedWeb of Science®Google Scholar Takasugi, M., Ramseyer, A. & Takasugi, J. (1977b) Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res- 37, 413. PubMedWeb of Science®Google Scholar Trinchieri, G. & Santoli, D. (1978) Anti-viral activity induced by culturing lymphocytes with tumor-derived on virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J. Exp. Med 147, 1314. 10.1084/jem.147.5.1314 CASPubMedWeb of Science®Google Scholar Trinchieri, G., Santoli, D., Dee, R.R. & Knowles, B.B. (1978) Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J. Exp. Med. 147, 1299. 10.1084/jem.147.5.1299 CASPubMedWeb of Science®Google Scholar Troye, M., Perlmann, P., Pape, G.R., Spiegelberg, H.L., Näslund, I. & Gidlöf, A. (1977) The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors. J. Immunol. 119, 1061. CASPubMedWeb of Science®Google Scholar Vose, B.M., Vánky, F. & Klein, E. (1978) Human tumor-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour infiltrating, blood and lymph node lymphocytes with autologous tumor ceils. Int. J. Cancer. press. Google Scholar Welsh, R.M., Jr. & Zinkernagel, R.M. (1977) Heterospecific cytotoxic cell activity induced during the first 3 days of acute lymphocytic choriomeningitis virus infection in mice. Nature 268, 646. 10.1038/268646a0 PubMedWeb of Science®Google Scholar Welsh, R.M. Jr.,, Zinkernagel, R.M. & Hallenbeck, L.A. (1978) Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. Specificities of the natural killer cells. Submitted for publication. Google Scholar West, W.H., Cannon, G.B., Kay, H.D., Bonnard, G.D. & Herberman, R.B. (1977) Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells, J. Immunol. 118, 355. CASPubMedWeb of Science®Google Scholar West, W.H., Boozer, R.B. & Herberman, R.B. (1978) Low affinity E-rosette formation by the human K cell. J. Immunol. 120, 90. PubMedWeb of Science®Google Scholar Wolfe, S.A., Tracey, D.E. & Henney, C.S. (1976) Induction of "natural killer" cells by BCG. Nature 262, 584. 10.1038/262584a0 CASPubMedWeb of Science®Google Scholar Yakir, Y., Kook, A. & Trainin, N. (1978) Enrichment of in vitro and in vivo immunologic activity of purified fractions of calf thymic hormone (THF). J. Exp. Med. In press. 10.1084/jem.148.1.71 PubMedWeb of Science®Google Scholar Citing Literature Volume44, Issue1April 1979Pages 43-70 ReferencesRelatedInformation
Referência(s)